Compte-rendu sur les hémopathies myéloïdes d'après le 54^e congrès de l'ASH American Society of Hematology, 8-11 décembre 2012, AtlantaVEY, Norbert.Correspondances en onco-hématologie. 2013, Vol 8, Num 1, issn 1954-4820, 25 p., SUP1Serial Issue

Cloretazine for the treatment of acute myeloid leukemiaVEY, Norbert; GILES, Frank.Expert review of anticancer therapy. 2006, Vol 6, Num 3, pp 321-328, issn 1473-7140, 8 p.Article

Quelle est la prise en charge actuelle des syndromes myélodysplasiques? : Syndromes myélodysplasiques = Current management of myelodysplastic syndromes : Myelodysplatic syndromesVEY, Norbert; CHARBONNIER, Aude.La Revue du praticien (Paris). 2010, Vol 60, Num 10, pp 1416-1419, issn 0035-2640, 4 p.Article

Leucémie myéloïde chronique: actualités cliniquesETIENNE, G; TULLIEZ, M.Correspondances en onco-hématologie. 2013, Vol 8, Num 1, pp 5-11, issn 1954-4820, 7 p., SUP1Article

Syndromes myéloprolifératifsCASADEVALL, N; DUPRIEZ, B.Correspondances en onco-hématologie. 2013, Vol 8, Num 1, pp 12-17, issn 1954-4820, 6 p., SUP1Article

Syndromes myélodysplasiquesGUERCI-BRESIER, A; ROSE, C.Correspondances en onco-hématologie. 2013, Vol 8, Num 1, pp 18-25, issn 1954-4820, 8 p., SUP1Article

Histone méthyltransférases: Une nouvelle classe de cibles thérapeutiques dans le traitement du cancer ? = Histone methyltransferases: a new class of therapeutic targets in cancer treatment?CHAIB, Hassiba; PREBET, Thomas; VEY, Norbert et al.MS. Médecine sciences. 2011, Vol 27, Num 8-9, pp 725-732, issn 0767-0974, 8 p.Article

Current status of reduced intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemiaBLAISE, Didier; VEY, Norbert; FAUCHER, Catherine et al.Haematologica (Roma). 2007, Vol 92, Num 4, pp 533-541, issn 0390-6078, 9 p.Article

Low blood dendritic cells in chronic myeloid leukaemia patients correlates with loss of CD34⁺/CD38^- primitive haematopoietic progenitorsMOHTY, Mohamad; ISNARDON, Daniel; VEY, Norbert et al.British journal of haematology. 2002, Vol 119, Num 1, pp 115-118, issn 0007-1048, 4 p.Article

Clofarabine Plus Cytarabine Compared With Cytarabine Alone in Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia: Results From the CLASSIC I TrialFADERL, Stefan; WETZLER, Meir; MARIS, Michael et al.Journal of clinical oncology. 2012, Vol 30, Num 20, pp 2492-2499, issn 0732-183X, 8 p.Article

Lenalidomide in lower-risk myelodysplastic syndromes with karyotypes other than deletion 5q and refractory to erythropoiesis-stimulating agentsSIBON, David; CANNAS, Giovanna; PERRIER, Herve et al.British journal of haematology. 2012, Vol 156, Num 5, pp 619-625, issn 0007-1048, 7 p.Article

A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remissionVEY, Norbert; BOURHIS, Jean-Henri; DOMBRET, Herve et al.Blood. 2012, Vol 120, Num 22, pp 4317-4323, issn 0006-4971, 7 p.Article

Mutations affecting mRNA splicing define distinct clinical phenotypes and correlate with patient outcome in myelodysplastic syndromesDAMM, Frederik; KOSMIDER, Olivier; GUERCI-BRESLER, Agnes et al.Blood. 2012, Vol 119, Num 14, pp 3211-3218, issn 0006-4971, 8 p.Article

Consent for Biobanking: Assessing the Understanding and Views of Cancer PatientsMANCINI, Julien; PELLEGRINI, Isabelle; VIRET, Frédéric et al.Journal of the National Cancer Institute. 2011, Vol 103, Num 2, pp 154-157, issn 0027-8874, 4 p.Article

Posttranscriptional deregulation of MYC via PTEN constitutes a major alternative pathway of MYC activation in T-cell acute lymphoblastic leukemiaBONNET, Melanie; LOOSVELD, Marie; MAMESSIER, Emilie et al.Blood. 2011, Vol 117, Num 24, pp 6650-6659, issn 0006-4971, 10 p.Article

TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs)KOSMIDER, Olivier; GELSI-BOYER, Véronique; VEY, Norbert et al.Blood. 2009, Vol 114, Num 15, pp 3285-3291, issn 0006-4971, 7 p.Article

Role of autologous hematopoietic stem cell transplantation according to the NPM1/FLT3-ITD molecular status for cytogenetically normal AML patients: A GOELAMS studyGUIEZE, Romain; CORNILLET-LEFEBVRE, Pascale; VEY, Norbert et al.American journal of hematology. 2012, Vol 87, Num 12, pp 1052-1056, issn 0361-8609, 5 p.Article

Single-Agent Laromustine, A Novel Alkylating Agent, Has Significant Activity in Older Patients With Previously Untreated Poor-Risk Acute Myeloid LeukemiaSCHILLER, Gary J. J; O'BRIEN, Susan M; ALBITAR, Maher X et al.Journal of clinical oncology. 2010, Vol 28, Num 5, pp 815-821, issn 0732-183X, 7 p.Article

Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experienceADES, Lionel; GUERCI, Agnes; TOURNILHAC, Olivier et al.Blood. 2010, Vol 115, Num 9, pp 1690-1696, issn 0006-4971, 7 p.Article

Phase 3 randomized, placebo-controlled, double-blind study of high-dose continuous infusion cytarabine alone or with laromustine (VNP40101M) in patients with acute myeloid leukemia in first relapseGILES, Francis; VEY, Norbert; KELL, Jonathan et al.Blood. 2009, Vol 114, Num 19, pp 4027-4033, issn 0006-4971, 7 p.Article

Safety of a weekly high dose of liposomal amphotericin B for prophylaxis of invasive fungal infection in immunocompromised patients : PROPHYSOME StudyCORDONNIER, Catherine; MOHTY, Mohamad; FAUCHER, Catherine et al.International journal of antimicrobial agents. 2008, Vol 31, Num 2, pp 135-141, issn 0924-8579, 7 p.Article

Secondary or Concomitant Neoplasms Among Adults Diagnosed With Acute Lymphoblastic Leukemia and Treated According to the LALA-87 and LALA-94 TrialsTAVERNIER, Emmanuelle; LE, Quoc-Hung; DE BOTTON, Stéphane et al.Cancer. 2007, Vol 110, Num 12, pp 2747-2755, issn 0008-543X, 9 p.Article

One versus two high-dose cytarabine-based consolidation before autologous stem cell transplantation for young acute myeloblastic leukaemia patients in first complete remissionJOURDAN, Eric; RIGAL-HUGUET, Francoise; CAILLERES, Sylvie et al.British journal of haematology. 2005, Vol 129, Num 3, pp 403-410, issn 0007-1048, 8 p.Article

Reduced intensity conditioning prior to allogeneic stem cell transplantation for patients with acute myeloblastic leukemia as a first-line treatmentBLAISE, Didier P; BOIRON, Jean Michel; FAUCHER, Catherine et al.Cancer. 2005, Vol 104, Num 9, pp 1931-1938, issn 0008-543X, 8 p.Article

International Randomized Phase III Study of Elacytarabine Versus Investigator Choice in Patients With Relapsed/Refractory Acute Myeloid LeukemiaROBOZ, Gail J; ROSENBLAT, Todd; HILLS, Robert et al.Journal of clinical oncology. 2014, Vol 32, Num 18, pp 1919-1926, issn 0732-183X, 8 p.Article